Log In
Print this Print this

ILV-095, PF-5212368 (formerly WAY-264095)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today